Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on August 2010 |
| Author/s |
author: Gabriella D'Andrea-Carlino |
| Publication date | August 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |